AIMC Topic: Basigin

Clear Filters Showing 1 to 2 of 2 articles

CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemia.

Cancer letters May 31, 2022
T cell acute lymphoblastic leukemia (T-ALL) is invasive and heterogeneous, and existing therapies are sometimes unsuccessful. Chimeric antigen receptor (CAR) T cell therapy is a breakthrough tumor treatment method, particularly for B cell acute lymph...
Humans Animals Receptors, Chimeric Antigen T-Lymphocytes Cell Line, Tumor Receptors, Antigen, T-Cell Mice Basigin Immunotherapy, Adoptive Mice, Inbred NOD Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
View on PubMed DOI

Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: a retrospective study.

BMC pulmonary medicine Dec 28, 2017
BACKGROUND: Previous studies show that overexpression of EMMPRIN involved in the malignant biological behavior of tumors. This investigation was to disclose the expression status of EMMPRIN in non-small cell lung cancer (NSCLC) and its clinical value...
Humans Retrospective Studies Female Risk Factors Biomarkers, Tumor Male Middle Aged ROC Curve Lung Neoplasms Gene Expression Regulation, Neoplastic Lymph Nodes Carcinoma, Non-Small-Cell Lung Lymphatic Metastasis Neoplasm Staging Immunohistochemistry Up-Regulation Basigin
View on PubMed DOI
Popular Topics
Recent Journals